Atyr Pharma, Stock Market Value
| ATYR Stock | 5.71 0.28 4.67% |
| Symbol | ATyr |
aTyr Pharma, Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATyr Pharma,. If investors know ATyr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATyr Pharma, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of aTyr Pharma, is measured differently than its book value, which is the value of ATyr that is recorded on the company's balance sheet. Investors also form their own opinion of ATyr Pharma,'s value that differs from its market value or its book value, called intrinsic value, which is ATyr Pharma,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATyr Pharma,'s market value can be influenced by many factors that don't directly affect ATyr Pharma,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATyr Pharma,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if ATyr Pharma, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATyr Pharma,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ATyr Pharma, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ATyr Pharma,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ATyr Pharma,.
| 04/23/2025 |
| 07/22/2025 |
If you would invest 0.00 in ATyr Pharma, on April 23, 2025 and sell it all today you would earn a total of 0.00 from holding aTyr Pharma, or generate 0.0% return on investment in ATyr Pharma, over 90 days. ATyr Pharma, is related to or competes with Cementos Pacasmayo, ChampionX, Highway Holdings, Griffon, Axcelis Technologies, Cleanaway Waste, and Primoris Services. ATyr Pharma, is entity of United States. It is traded as Stock on NASDAQ exchange. More
ATyr Pharma, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ATyr Pharma,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess aTyr Pharma, upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.06 | |||
| Information Ratio | 0.2147 | |||
| Maximum Drawdown | 19.68 | |||
| Value At Risk | (5.27) | |||
| Potential Upside | 7.78 |
ATyr Pharma, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ATyr Pharma,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ATyr Pharma,'s standard deviation. In reality, there are many statistical measures that can use ATyr Pharma, historical prices to predict the future ATyr Pharma,'s volatility.| Risk Adjusted Performance | 0.2393 | |||
| Jensen Alpha | 0.9845 | |||
| Total Risk Alpha | 0.4341 | |||
| Sortino Ratio | 0.229 | |||
| Treynor Ratio | 1.77 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ATyr Pharma,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
aTyr Pharma, Backtested Returns
ATyr Pharma, appears to be slightly risky, given 3 months investment horizon. aTyr Pharma, secures Sharpe Ratio (or Efficiency) of 0.2, which signifies that the company had a 0.2 % return per unit of risk over the last 3 months. By analyzing ATyr Pharma,'s technical indicators, you can evaluate if the expected return of 0.89% is justified by implied risk. Please makes use of ATyr Pharma,'s Semi Deviation of 3.32, risk adjusted performance of 0.2393, and Downside Deviation of 4.06 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, ATyr Pharma, holds a performance score of 15. The firm shows a Beta (market volatility) of 0.6, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ATyr Pharma,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding ATyr Pharma, is expected to be smaller as well. Please check ATyr Pharma,'s sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to make a quick decision on whether ATyr Pharma,'s price patterns will revert.
Auto-correlation | 0.78 |
Good predictability
aTyr Pharma, has good predictability. Overlapping area represents the amount of predictability between ATyr Pharma, time series from 23rd of April 2025 to 7th of June 2025 and 7th of June 2025 to 22nd of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of aTyr Pharma, price movement. The serial correlation of 0.78 indicates that around 78.0% of current ATyr Pharma, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.78 | |
| Spearman Rank Test | 0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
aTyr Pharma, lagged returns against current returns
Autocorrelation, which is ATyr Pharma, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ATyr Pharma,'s stock expected returns. We can calculate the autocorrelation of ATyr Pharma, returns to help us make a trade decision. For example, suppose you find that ATyr Pharma, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ATyr Pharma, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ATyr Pharma, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ATyr Pharma, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ATyr Pharma, stock over time.
Current vs Lagged Prices |
| Timeline |
ATyr Pharma, Lagged Returns
When evaluating ATyr Pharma,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ATyr Pharma, stock have on its future price. ATyr Pharma, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ATyr Pharma, autocorrelation shows the relationship between ATyr Pharma, stock current value and its past values and can show if there is a momentum factor associated with investing in aTyr Pharma,.
Regressed Prices |
| Timeline |
Pair Trading with ATyr Pharma,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ATyr Pharma, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma, will appreciate offsetting losses from the drop in the long position's value.Moving together with ATyr Stock
The ability to find closely correlated positions to ATyr Pharma, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ATyr Pharma, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ATyr Pharma, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling aTyr Pharma, to buy it.
The correlation of ATyr Pharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ATyr Pharma, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if aTyr Pharma, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ATyr Pharma, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for ATyr Stock Analysis
When running ATyr Pharma,'s price analysis, check to measure ATyr Pharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma, is operating at the current time. Most of ATyr Pharma,'s value examination focuses on studying past and present price action to predict the probability of ATyr Pharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma,'s price. Additionally, you may evaluate how the addition of ATyr Pharma, to your portfolios can decrease your overall portfolio volatility.